JPS6041077B2
(en)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
Cis platinum(2) complex of 1,2-diaminocyclohexane isomer
|
US4261989A
(en)
|
1979-02-19 |
1981-04-14 |
Kaken Chemical Co. Ltd. |
Geldanamycin derivatives and antitumor drug
|
JPS62135835A
(en)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
Method for processing silver halide color photographic sensitive material
|
JPS62135830A
(en)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
Silver halide color photographic sensitive material and method for processing it
|
JPS62135834A
(en)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
Method for processing silver halide color photographic sensitive material
|
JPS62135832A
(en)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
Method for processing silver halide color photographic sensitive material
|
JPS62136651A
(en)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
Silver halide color photographic sensitive material and processing method therefor
|
JPS62136654A
(en)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
Processing method for silver halide photographic sensitive material
|
JPS62136650A
(en)
|
1985-12-11 |
1987-06-19 |
Fuji Photo Film Co Ltd |
Silver halide color photographic sensitive material and processing method therefor
|
JPS62206545A
(en)
|
1986-03-07 |
1987-09-11 |
Fuji Photo Film Co Ltd |
Silver halide photographic sensitive material
|
GB8729614D0
(en)
|
1987-12-18 |
1988-02-03 |
Beecham Group Plc |
Novel compounds
|
US5266573A
(en)
|
1989-08-07 |
1993-11-30 |
Elf Sanofi |
Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
|
US5360459A
(en)
|
1991-05-13 |
1994-11-01 |
The Lubrizol Corporation |
Copper-containing organometallic complexes and concentrates and diesel fuels containing same
|
JPH05196976A
(en)
|
1991-11-18 |
1993-08-06 |
Toshiba Corp |
Organic nonlinear optical element
|
JPH05181221A
(en)
|
1991-12-27 |
1993-07-23 |
Konica Corp |
Silver halide photographic sensitive material
|
GB9201755D0
(en)
|
1992-01-28 |
1992-03-11 |
British Bio Technology |
Compounds
|
FR2687932A1
(en)
|
1992-02-27 |
1993-09-03 |
Oreal |
OIL-IN-WATER DISPERSION CAPABLE OF FORMING COMPOSITE FILMS.
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
WO1998006709A1
(en)
|
1996-08-14 |
1998-02-19 |
Takeda Chemical Industries, Ltd. |
Cyclic urea compounds, their production and use as herbicides
|
US5977134A
(en)
|
1996-12-05 |
1999-11-02 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6117973A
(en)
|
1997-02-24 |
2000-09-12 |
Georgia Tech Research Corp. |
PNA monomers with electron donor or acceptor
|
FR2761687B1
(en)
|
1997-04-08 |
2000-09-15 |
Centre Nat Rech Scient |
QUINOLEIN DERIVATIVES, ESPECIALLY HAVING ANTIVIRAL PROPERTIES, THEIR PREPARATIONS AND THEIR BIOLOGICAL APPLICATIONS
|
JP2000072695A
(en)
|
1998-08-24 |
2000-03-07 |
Sumitomo Pharmaceut Co Ltd |
Cyclic compound
|
WO2000076984A2
(en)
|
1999-05-21 |
2000-12-21 |
Biovitrum Ab |
Novel compounds, their use and preparation
|
US6465467B1
(en)
|
1999-05-21 |
2002-10-15 |
Biovitrum Ab |
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
|
PE20010306A1
(en)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM USEFUL FOR THE INHIBITION OF PROTEIN KINASE
|
EP1204645A2
(en)
|
1999-08-04 |
2002-05-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US6514964B1
(en)
|
1999-09-27 |
2003-02-04 |
Amgen Inc. |
Fused cycloheptane and fused azacycloheptane compounds and their methods of use
|
ATE312100T1
(en)
|
1999-09-28 |
2005-12-15 |
Eisai Co Ltd |
QUINUCLIDINE COMPOUNDS AND MEDICATIONS THAT CONTAIN THESE AS ACTIVE INGREDIENTS
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
JP4548761B2
(en)
|
2000-06-15 |
2010-09-22 |
富士フイルムホールディングス株式会社 |
Lubricant composition
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
DE10032633A1
(en)
|
2000-07-05 |
2002-01-17 |
Bayer Ag |
Method for finding protoporphyrinogen oxidase inhibitors
|
JP2002122954A
(en)
|
2000-08-08 |
2002-04-26 |
Fuji Photo Film Co Ltd |
Photosensitive silver halide photographic emulsion, silver halide photographic material containing the same and method for enhancing sensitivity of photosensitive silver halide photographic emulsion
|
WO2002015910A1
(en)
|
2000-08-18 |
2002-02-28 |
Sterix Limited |
2-substituted estradiol derivative for inhibiting superoxid dismutase
|
WO2002028813A1
(en)
|
2000-09-30 |
2002-04-11 |
Loctite |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
US6963001B2
(en)
|
2000-09-30 |
2005-11-08 |
Henkel Corporation |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
AU2002213467A8
(en)
|
2000-10-11 |
2009-07-30 |
Chemocentryx Inc |
Modulation of ccr4 function
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
SE0103646D0
(en)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic chroman compounds
|
NZ526697A
(en)
|
2001-01-16 |
2005-05-27 |
Astrazeneca Ab |
Therapeutic heterocyclic compounds
|
MXPA03006268A
(en)
|
2001-01-16 |
2003-09-22 |
Astrazeneca Ab |
Therapeutic chromone compounds.
|
CA2439666A1
(en)
|
2001-03-01 |
2002-09-12 |
Shionogi & Co., Ltd. |
Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
|
PT1383731E
(en)
|
2001-04-06 |
2009-11-03 |
Biocryst Pharm Inc |
Biaryl compounds as serine protease inhibitors
|
WO2003003009A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
|
WO2003003008A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Chemical libraries useful for drug discovery processes
|
JO3429B1
(en)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
Hiv inhibiting pyrimidines derivatives
|
FR2831536A1
(en)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
NOVEL BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS KDR INHIBITORS
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
EP1478648B1
(en)
|
2002-02-01 |
2014-04-30 |
ARIAD Pharmaceuticals, Inc. |
Phosphorus-containing compounds and uses thereof
|
PT1482924E
(en)
|
2002-03-05 |
2008-08-27 |
Axys Pharm Inc |
Cathepsin cysteine protease inhibitors
|
WO2003078446A2
(en)
|
2002-03-15 |
2003-09-25 |
Nuevolution A/S |
A building block forming a c-c or a c-hetero atom bond upon reaction
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
JP2006511460A
(en)
|
2002-08-23 |
2006-04-06 |
ユニバーシティ オブ コネチカット |
Ketocannabinoids with therapeutic indications
|
WO2004056746A1
(en)
|
2002-12-23 |
2004-07-08 |
4Sc Ag |
Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
TWI344955B
(en)
|
2003-03-14 |
2011-07-11 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
GB0306430D0
(en)
|
2003-03-20 |
2003-04-23 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalysts
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
WO2004101529A1
(en)
|
2003-05-19 |
2004-11-25 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic compound and medical use thereof
|
US7399865B2
(en)
|
2003-09-15 |
2008-07-15 |
Wyeth |
Protein tyrosine kinase enzyme inhibitors
|
JP4231379B2
(en)
|
2003-10-15 |
2009-02-25 |
富士フイルム株式会社 |
Lubricant composition
|
JP2005170939A
(en)
|
2003-11-20 |
2005-06-30 |
Takeda Chem Ind Ltd |
Prophylactic/therapeutic agent for diabetes
|
DE10355066A1
(en)
|
2003-11-25 |
2005-06-23 |
Basf Ag |
Process for asymmetric synthesis
|
US7632946B2
(en)
|
2004-02-06 |
2009-12-15 |
Abbott Laboratories |
Naphthyridine-based antibacterial compositions
|
JP4829506B2
(en)
|
2004-02-17 |
2011-12-07 |
石原産業株式会社 |
Thioamide compounds or salts thereof, and cytokine production inhibitors containing them
|
JP4790703B2
(en)
|
2004-04-07 |
2011-10-12 |
武田薬品工業株式会社 |
Cyclic compounds
|
EP1595888A1
(en)
|
2004-05-11 |
2005-11-16 |
Degussa AG |
Cycloolefin phosphine ligands and their use in catalysis
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
EP1760071A4
(en)
|
2004-06-23 |
2008-03-05 |
Ono Pharmaceutical Co |
Compound having s1p receptor binding potency and use thereof
|
GB0415879D0
(en)
|
2004-07-15 |
2004-08-18 |
Bp Chem Int Ltd |
Polymerisation catalyst
|
GB0418022D0
(en)
|
2004-08-12 |
2004-09-15 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalyst
|
EA201890903A9
(en)
|
2004-09-02 |
2021-11-10 |
Дженентек, Инк. |
COMPOUNDS OF PYRIDYL INHIBITORS OF SIGNAL TRANSMISSION BY HEDGEHOG PROTEIN, METHOD FOR THEIR PREPARATION, COMPOSITION AND METHODS FOR TREATING CANCER AND INHIBITING ANGIOGENESIS AND SIGNAL PATH OF HEDGEHOG IN FLAGS
|
GB0420396D0
(en)
|
2004-09-14 |
2004-10-13 |
Bp Chem Int Ltd |
Polyolefins
|
WO2006038594A1
(en)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N-type calcium channel inhibitor
|
WO2006061094A1
(en)
|
2004-12-11 |
2006-06-15 |
Merck Patent Gmbh |
Liquid crystal compounds, liquid crystal medium and liquid crystal display
|
EP1841736A1
(en)
|
2005-01-19 |
2007-10-10 |
Biolipox AB |
Indoles useful in the treatment of inflammation
|
JP4749000B2
(en)
|
2005-02-22 |
2011-08-17 |
富士フイルム株式会社 |
Grease composition
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
EP1867704B1
(en)
|
2005-03-15 |
2010-09-15 |
FUJIFILM Corporation |
Surface treatment method using disc-like compound, (lubricating) composition for surface treatment, and surface-treated article
|
US20060156481A1
(en)
|
2005-03-22 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
AU2006230366A1
(en)
|
2005-03-31 |
2006-10-05 |
Lightwave Logic, Inc. |
Heterocyclical chromophore architectures with novel electronic acceptor systems
|
PL1871374T3
(en)
|
2005-04-21 |
2011-12-30 |
Merck Serono Sa |
2,3 substituted pyrazine sulfonamides as inhibitors of crth2
|
CA2605738C
(en)
|
2005-04-25 |
2013-10-01 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Novel azaheterocyclic compounds as kinase inhibitors
|
EP1883687A1
(en)
|
2005-05-09 |
2008-02-06 |
Technische Universität Braunschweig |
Light emitting compound for electroluminescent applications
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
EP1896466B1
(en)
|
2005-06-27 |
2011-04-13 |
Bristol-Myers Squibb Company |
N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
US7700620B2
(en)
|
2005-06-27 |
2010-04-20 |
Bristol-Myers Squibb Company |
C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
WO2007011759A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
WO2007011721A1
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
JP2007056213A
(en)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
Composition for sintered oil-containing bearing oil, bearing device and sliding member using the same
|
NZ593684A
(en)
|
2005-10-19 |
2012-11-30 |
Gruenenthal Chemie |
Novel vanilloid receptor ligands and their use for producing medicaments
|
FR2892859B1
(en)
|
2005-10-27 |
2008-06-06 |
Commissariat Energie Atomique |
METHOD OF GRAFTING MOLECULES OF INTEREST ON INORGANIC SURFACES, SURFACES OBTAINED AND APPLICATIONS
|
CA2630920A1
(en)
|
2005-11-22 |
2007-05-31 |
University Of South Florida |
Inhibition of cell proliferation
|
WO2007064869A2
(en)
|
2005-12-01 |
2007-06-07 |
Yale University |
Catalysts for aryl sulfide synthesis and method of producing aryl sulfides
|
JP2008007634A
(en)
|
2006-06-29 |
2008-01-17 |
Fujifilm Corp |
Lubricant composition
|
AU2007288188A1
(en)
|
2006-08-23 |
2008-02-28 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
US8414983B2
(en)
|
2006-09-02 |
2013-04-09 |
MERCK Patent Gesellschaft mit beschränkter Haftung |
Particle beam process for the alignment of reactive mesogens
|
WO2008118626A2
(en)
|
2007-03-08 |
2008-10-02 |
Burnham Institute For Medical Research |
Inhibitors of jnk and methods for identifying inhibitors of jnk
|
US7956020B2
(en)
|
2007-03-29 |
2011-06-07 |
Fujifilm Corporation |
Lubricant composition, mechanical element, and method for producing triazine derivatives
|
WO2008125811A1
(en)
|
2007-04-11 |
2008-10-23 |
Astrazeneca Ab |
N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
|
JP5539864B2
(en)
|
2007-06-12 |
2014-07-02 |
アカオゲン,インコーポレーテッド |
Antibacterial agent
|
US8063165B2
(en)
|
2007-06-18 |
2011-11-22 |
Bridgestone Corporation |
Functional polymers prepared with sulfur-containing initiators
|
JP2009013314A
(en)
|
2007-07-06 |
2009-01-22 |
Toyo Ink Mfg Co Ltd |
Photocurable type ink
|
EP2195656A4
(en)
|
2007-08-21 |
2011-10-19 |
Senomyx Inc |
Human t2r bitterness receptors and uses thereof
|
US8143276B2
(en)
|
2007-08-22 |
2012-03-27 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
EP2181175A1
(en)
|
2007-08-29 |
2010-05-05 |
Merck Patent GmbH |
Liquid crystal display
|
WO2009026720A1
(en)
|
2007-08-29 |
2009-03-05 |
Methylgene Inc. |
Processes and intermediates for preparing fused heterocyclic kinase inhibitors
|
MX338504B
(en)
|
2007-09-12 |
2016-04-20 |
Genentech Inc |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use.
|
US9340506B2
(en)
|
2007-10-08 |
2016-05-17 |
Advinus Therapeutics Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
BRPI0818501A2
(en)
|
2007-10-08 |
2015-04-22 |
Advinus Therapeutics Private Ltd |
Acetamide derivatives as glycokinase activators, their process and medicinal applications
|
US8354528B2
(en)
|
2007-10-25 |
2013-01-15 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
CN101918389A
(en)
|
2007-11-02 |
2010-12-15 |
梅特希尔基因公司 |
Histone deacetylase inhibitor
|
WO2009078813A1
(en)
|
2007-12-19 |
2009-06-25 |
Nanyang Technological University |
Method of forming oseltamivir and derivatives thereof
|
EP2098226A1
(en)
|
2008-03-06 |
2009-09-09 |
Forschungsverbund Berlin e.V. |
AKAP-PKA interaction inhibitors for use in the treatment of heart diseases
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
US9174969B2
(en)
|
2008-07-21 |
2015-11-03 |
University Of South Florida |
Indoline scaffold SHP-2 inhibitors and cancer treatment method
|
WO2010012363A1
(en)
|
2008-07-28 |
2010-02-04 |
Merck Patent Gmbh |
Liquid-crystal display
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
CN102264866B
(en)
|
2008-12-22 |
2014-06-18 |
默克专利股份有限公司 |
Liquid crystal display
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
DE102010006691A1
(en)
|
2009-02-06 |
2010-10-28 |
Merck Patent Gmbh |
Liquid-crystalline medium and liquid-crystal display
|
WO2010094029A2
(en)
|
2009-02-16 |
2010-08-19 |
University Of South Florida |
Asymmetric cyclopropanation with succinimidyl diazoacetate
|
EP2398474A4
(en)
|
2009-02-23 |
2012-12-05 |
Presidio Pharmaceuticals Inc |
Inhibitors of hcv ns5a
|
JP2010217692A
(en)
|
2009-03-18 |
2010-09-30 |
Konica Minolta Holdings Inc |
Display element
|
CA2756873C
(en)
|
2009-04-02 |
2018-01-09 |
Joaquin Pastor Fernandez |
Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
|
WO2010115098A2
(en)
|
2009-04-03 |
2010-10-07 |
The Scripps Research Institute |
Palladium-catalyzed ortho-fluorination
|
DE102010012900A1
(en)
|
2009-04-23 |
2010-11-25 |
Merck Patent Gmbh |
liquid-crystal display
|
ES2659725T3
(en)
|
2009-05-05 |
2018-03-19 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and disorder treatment procedure
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
US20120232108A1
(en)
|
2009-06-16 |
2012-09-13 |
Xianhai Huang |
Gamma secretase modulators
|
US20120245158A1
(en)
|
2009-06-16 |
2012-09-27 |
Xianhai Huang |
Gamma secretase modulators
|
EP2443121A2
(en)
|
2009-06-16 |
2012-04-25 |
Schering Corporation |
Gamma secretase modulators
|
CA2766033C
(en)
|
2009-06-25 |
2016-09-20 |
Alkermes, Inc. |
Prodrugs of nh-acidic compounds
|
WO2010148422A1
(en)
|
2009-06-25 |
2010-12-29 |
Walter And Eliza Hall Institute Of Medical Research |
Compounds and methods for treating parasitic infestations
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
US9340528B2
(en)
|
2009-09-04 |
2016-05-17 |
Bayer Pharma Aktiengesellschaft |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
|
EP2292720A1
(en)
|
2009-09-08 |
2011-03-09 |
Merck Patent GmbH |
Liquid-crystal display
|
WO2011056929A1
(en)
|
2009-11-04 |
2011-05-12 |
Massachusetts Institute Of Technology |
Continuous flow synthesis of amino alcohols using microreactors
|
KR20110088098A
(en)
|
2010-01-28 |
2011-08-03 |
다우어드밴스드디스플레이머티리얼 유한회사 |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
WO2011101644A1
(en)
|
2010-02-18 |
2011-08-25 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Triazolo [4, 5 - b] pyridin derivatives
|
EP2542081A4
(en)
|
2010-03-01 |
2013-07-31 |
Gtx Inc |
Compounds for treatment of cancer
|
KR20110101444A
(en)
|
2010-03-08 |
2011-09-16 |
다우어드밴스드디스플레이머티리얼 유한회사 |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
KR20110104765A
(en)
|
2010-03-17 |
2011-09-23 |
다우어드밴스드디스플레이머티리얼 유한회사 |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
WO2011140425A1
(en)
|
2010-05-06 |
2011-11-10 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
CN103038229B
(en)
|
2010-05-26 |
2016-05-11 |
桑诺维恩药品公司 |
Heteroaryl compound and using method thereof
|
CN103096875B
(en)
|
2010-06-03 |
2016-08-17 |
阿尔尼拉姆医药品有限公司 |
Biodegradable lipid for delivery of active agent
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
EP2598483B1
(en)
|
2010-07-29 |
2020-07-29 |
Rigel Pharmaceuticals, Inc. |
Ampk-activating heterocyclic compounds and methods for using the same
|
WO2012016188A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
WO2012020357A1
(en)
|
2010-08-09 |
2012-02-16 |
Advinus Therapeutics Ltd. |
Acetamide compounds, their process and pharmaceutical application
|
WO2012020215A1
(en)
|
2010-08-09 |
2012-02-16 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
|
BR112013003815A2
(en)
|
2010-08-20 |
2019-09-24 |
Gruenenthal Chemie |
substituted cyclic carboxamide derivatives and urea derivatives as vanyloid receptor ligands
|
WO2012049624A1
(en)
|
2010-10-14 |
2012-04-19 |
Koninklijke Philips Electronics N.V. |
Pretargeting kit, method and agents used therein
|
WO2012052540A1
(en)
|
2010-10-21 |
2012-04-26 |
Universitaet Des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
CN103180332A
(en)
|
2010-10-28 |
2013-06-26 |
巴斯夫欧洲公司 |
N-heterocyclic carbene complexes, their preparation and use
|
US20120108819A1
(en)
|
2010-10-28 |
2012-05-03 |
Basf Se |
N-Heterocyclic Carbene Complexes, Their Preparation And Use
|
KR20120045905A
(en)
|
2010-11-01 |
2012-05-09 |
한국화학연구원 |
Heterocyclic ring fused pyrido compounds and process for preparing them
|
US9090633B2
(en)
|
2010-11-18 |
2015-07-28 |
Kasina Laila Innova Pharmaceuticals Private Limited |
Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
|
US20140018540A1
(en)
|
2010-12-14 |
2014-01-16 |
Electrophoretics Limited |
Casein kinase 1delta (ck 1delta) inhibitors
|
US9427482B2
(en)
|
2010-12-21 |
2016-08-30 |
Koninklijke Philips N.V. |
Agents for clearing biomolecules from circulation
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
JP5618815B2
(en)
|
2010-12-24 |
2014-11-05 |
富士フイルム株式会社 |
Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film and pattern formation method using the composition
|
TWI450891B
(en)
|
2010-12-29 |
2014-09-01 |
Dev Center Biotechnology |
Novel tubulin inhibitors
|
WO2012116135A2
(en)
|
2011-02-24 |
2012-08-30 |
Emory University |
Noggin blocking compositions for ossification and methods related thereto
|
EP2681196B1
(en)
|
2011-03-04 |
2015-09-09 |
Life Technologies Corporation |
Compounds and methods for conjugation of biomolecules
|
US10280171B2
(en)
|
2016-05-31 |
2019-05-07 |
Board Of Regents, The University Of Texas System |
Heterocyclic inhibitors of PTPN11
|
DE102012003796A1
(en)
|
2011-03-18 |
2012-09-20 |
Merck Patent Gmbh |
Liquid crystalline medium
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
JP2014516366A
(en)
|
2011-03-29 |
2014-07-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Liquid crystal medium
|
US20140163229A1
(en)
|
2011-04-07 |
2014-06-12 |
Cornell University |
Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same
|
EP2522369A1
(en)
|
2011-05-09 |
2012-11-14 |
Koninklijke Philips Electronics N.V. |
Pretargeting kit, method and agents used therein
|
EP3552664A1
(en)
|
2011-05-12 |
2019-10-16 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators
|
WO2012156919A1
(en)
|
2011-05-16 |
2012-11-22 |
Koninklijke Philips Electronics N.V. |
Bio-orthogonal drug activation
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
JP5782836B2
(en)
|
2011-05-27 |
2015-09-24 |
コニカミノルタ株式会社 |
ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, AND COMPOUND
|
US9073801B2
(en)
|
2011-06-03 |
2015-07-07 |
Massachusetts Institute Of Technology |
Z-selective ring-closing metathesis reactions
|
WO2013000532A1
(en)
|
2011-06-28 |
2013-01-03 |
Merck Patent Gmbh |
Indaceno derivatives as organic semiconductors
|
KR102082361B1
(en)
|
2011-07-07 |
2020-04-14 |
메르크 파텐트 게엠베하 |
Liquid-crystalline medium
|
US20140131628A1
(en)
|
2011-07-08 |
2014-05-15 |
Merck Patent Gmbh |
Conjugated polymers
|
DK2753605T3
(en)
|
2011-09-09 |
2019-06-17 |
Lantheus Medical Imaging Inc |
COMPOSITIONS, METHODS AND SYSTEMS FOR THE SYNTHESIS AND THE APPLICATION OF IMAGE CRAFTS
|
MX352672B
(en)
|
2011-09-27 |
2017-12-04 |
Amgen Inc |
Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer.
|
EP2615083A1
(en)
|
2012-01-10 |
2013-07-17 |
Studiengesellschaft Kohle mbH |
Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst
|
JP5814141B2
(en)
|
2012-01-23 |
2015-11-17 |
ユー・ディー・シー アイルランド リミテッド |
Synthesis method, compound synthesized using the synthesis method, and organic electroluminescence device
|
JP6396216B2
(en)
|
2012-02-22 |
2018-09-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Liquid crystal medium
|
US9217050B2
(en)
|
2012-04-03 |
2015-12-22 |
3M Innovative Properties Company |
Crosslinkable composition comprising photobase generators
|
EP2838893B1
(en)
|
2012-04-20 |
2019-03-13 |
Bayer Cropscience AG |
N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
|
FR2992317B1
(en)
|
2012-06-22 |
2016-05-13 |
Diverchim |
PROCESS FOR THE PREPARATION OF CHIRAL PEPTIDES
|
US8575283B1
(en)
|
2012-06-28 |
2013-11-05 |
Formosa Plastics Corporation, U.S.A. |
Heterocyclic organic compounds as electron donors for polyolefin catalysts
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
LT2894151T
(en)
|
2012-09-04 |
2021-09-10 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Imidazoline derivatives, preparation methods thereof, and their applications in medicine
|
WO2014045305A1
(en)
|
2012-09-21 |
2014-03-27 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
JPWO2014068893A1
(en)
|
2012-10-29 |
2016-09-08 |
コニカミノルタ株式会社 |
Retardation film, circularly polarizing plate, and image display device
|
MX2015005882A
(en)
|
2012-11-16 |
2015-09-23 |
Basf Se |
Lubricant compositions comprising epoxide compounds to improve fluoropolymer seal compatibility.
|
WO2014081303A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
WO2014081301A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
US9580653B2
(en)
|
2012-12-12 |
2017-02-28 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
JP6335428B2
(en)
|
2012-12-21 |
2018-05-30 |
出光興産株式会社 |
Organic electroluminescence device and electronic device
|
US20150340627A1
(en)
|
2013-01-03 |
2015-11-26 |
Merck Patent Gmbh |
Materials for electronic devices
|
WO2014122933A1
(en)
|
2013-02-08 |
2014-08-14 |
ソニー株式会社 |
Organic electroluminescent element
|
CA2901577A1
(en)
|
2013-02-18 |
2014-08-21 |
The Scripps Research Institute |
Modulators of vasopressin receptors with therapeutic potential
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
US9487472B2
(en)
|
2013-02-26 |
2016-11-08 |
President And Fellows Of Harvard College |
Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transfer
|
WO2014141129A2
(en)
|
2013-03-14 |
2014-09-18 |
Grueneberg Dorre A |
Novel methods, compounds, and compositions for inhibition of ros
|
US9290528B1
(en)
|
2013-03-15 |
2016-03-22 |
University Of Kentucky Research Foundation |
Light-activated compounds
|
JP5902641B2
(en)
|
2013-03-27 |
2016-04-13 |
富士フイルム株式会社 |
Optical interference pigment and method for producing the same
|
JP2016520552A
(en)
|
2013-04-05 |
2016-07-14 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
PPAR agonist
|
US10069079B2
(en)
|
2013-04-08 |
2018-09-04 |
Merck Patent Gmbh |
Organic electroluminescent device with thermally activated delayed fluorescence material
|
KR102177883B1
(en)
|
2013-04-08 |
2020-11-12 |
메르크 파텐트 게엠베하 |
Organic electroluminescent device
|
US9522881B2
(en)
|
2013-04-26 |
2016-12-20 |
Indiana University Research And Technology Corporation |
Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)
|
JP2014232188A
(en)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
Cellulose acylate film, circularly polarizing plate and image display device
|
CA2953482A1
(en)
|
2013-07-03 |
2015-01-08 |
Indiana University Research & Technology Corporation |
Shp2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using shp2 inhibitors
|
US9862789B2
(en)
|
2013-07-03 |
2018-01-09 |
University Of Connecticut |
Polymerization of diene monomers
|
US10478445B2
(en)
|
2013-07-03 |
2019-11-19 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
GB201312991D0
(en)
|
2013-07-19 |
2013-09-04 |
Isis Innovation |
Process
|
CN104371744B
(en)
|
2013-08-02 |
2019-01-01 |
默克专利股份有限公司 |
Liquid crystal media
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
WO2015042375A1
(en)
|
2013-09-20 |
2015-03-26 |
Idenix Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
KR101628288B1
(en)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
Composition for manufacturing optical elements with negative optical dispersion and optically anisotropic body manufactured therefrom
|
EP2857405A1
(en)
|
2013-10-01 |
2015-04-08 |
Studiengesellschaft Kohle mbH |
Process for the trans-selective hydroboration of internal alkynes
|
JP6487430B2
(en)
|
2013-10-21 |
2019-03-20 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Heteroaryl compounds as BTK inhibitors and their use
|
JP6088995B2
(en)
|
2013-10-24 |
2017-03-01 |
出光興産株式会社 |
Organic electroluminescence device and electronic device
|
JP6522313B2
(en)
|
2013-10-24 |
2019-05-29 |
出光興産株式会社 |
Organic electroluminescent device and electronic device
|
KR101537860B1
(en)
|
2013-11-22 |
2015-07-20 |
롯데케미칼 주식회사 |
Polycarbonate composite increased gamma-radiation resistant property and molded article using same
|
JP6215674B2
(en)
|
2013-11-29 |
2017-10-18 |
出光興産株式会社 |
Organic electroluminescence device and electronic device
|
JP6309834B2
(en)
|
2013-12-11 |
2018-04-11 |
株式会社Adeka |
Coloring composition
|
JP2015163671A
(en)
|
2013-12-13 |
2015-09-10 |
株式会社Adeka |
Radical-polymerizable composition
|
EP2883934B1
(en)
|
2013-12-16 |
2019-11-13 |
Merck Patent GmbH |
Liquid-crystalline medium
|
US10020455B2
(en)
|
2014-01-07 |
2018-07-10 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
|
WO2015106025A1
(en)
|
2014-01-09 |
2015-07-16 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Substituted benzoxazine and related compounds
|
WO2015107493A1
(en)
|
2014-01-17 |
2015-07-23 |
Novartis Ag |
1 -pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
|
JP6473457B2
(en)
|
2014-01-17 |
2019-02-20 |
ノバルティス アーゲー |
1- (Triazin-3-yl / pyridazin-3-yl) -piperidine / piperazine derivatives and compositions thereof for inhibiting the activity of SHP2
|
JO3517B1
(en)
|
2014-01-17 |
2020-07-05 |
Novartis Ag |
N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2
|
KR20150091942A
(en)
|
2014-02-04 |
2015-08-12 |
삼성전자주식회사 |
Organometallic compound and organic light emitting diode including the same
|
JP6313604B2
(en)
|
2014-02-05 |
2018-04-18 |
富士フイルム株式会社 |
Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, mask blank provided with actinic ray-sensitive or radiation-sensitive film, pattern formation method, and electronic device manufacturing method
|
AU2015223049B2
(en)
|
2014-02-27 |
2019-03-21 |
Merck Patent Gmbh |
Heterocyclic compounds as NaV channel inhibitors and uses thereof
|
EP3114109A4
(en)
|
2014-03-07 |
2017-10-18 |
The Johns Hopkins University |
Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
|
MX2020010847A
(en)
|
2014-05-13 |
2021-07-16 |
Hoffmann La Roche |
Deuterated heterocyclic compounds and their use as imaging agents.
|
PT3142637T
(en)
|
2014-05-16 |
2020-10-15 |
Olaplex Inc |
Keratin treatment formulations and methods
|
AR100530A1
(en)
|
2014-05-19 |
2016-10-12 |
Merial Inc |
ANTIHELMINE COMPOUNDS
|
EP3152192A1
(en)
|
2014-06-05 |
2017-04-12 |
Merck Patent GmbH |
Novel quinoline derivatives and their use in neurodegenerative diseases
|
WO2016010485A1
(en)
|
2014-07-16 |
2016-01-21 |
Agency For Science, Technology And Research |
Donor-acceptor polymers
|
US9818959B2
(en)
|
2014-07-29 |
2017-11-14 |
Arizona Board of Regents on behlaf of Arizona State University |
Metal-assisted delayed fluorescent emitters containing tridentate ligands
|
WO2016022645A1
(en)
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
US9947876B2
(en)
|
2014-08-26 |
2018-04-17 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescence device and electronic device
|
US10205190B2
(en)
|
2014-08-28 |
2019-02-12 |
Samsung Electronics Co., Ltd. |
Composite electrolyte including polymeric ionic liquid and inorganic particles and lithium battery including the same
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
AU2015360416A1
(en)
|
2014-12-10 |
2017-06-08 |
Massachusetts Institute Of Technology |
Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
|
KR102384224B1
(en)
|
2014-12-30 |
2022-04-08 |
삼성전자주식회사 |
Condensed-cyclic compound and organic light emitting device including the same
|
WO2016145383A1
(en)
|
2015-03-11 |
2016-09-15 |
Board Of Regents, University Of Texas System |
Mth1 inhibitors for treating disease
|
KR102434696B1
(en)
|
2015-03-13 |
2022-08-22 |
삼성전자주식회사 |
Organometallic compound and organic light emitting device including the same
|
ES2898765T3
(en)
|
2015-04-10 |
2022-03-08 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
EP3283462B1
(en)
|
2015-04-15 |
2020-12-02 |
Araxes Pharma LLC |
Fused-tricyclic inhibitors of kras and methods of use thereof
|
BR112017023780A2
(en)
|
2015-05-07 |
2018-07-31 |
Bristol-Myers Squibb Company |
tricyclic sulfones as rorgama modulators
|
US9458308B1
(en)
|
2015-05-12 |
2016-10-04 |
Lotte Chemical Corporation |
Polycarbonate resin composition with increased gamma-radiation resistant property and molded article using the same
|
US9879039B2
(en)
|
2015-06-03 |
2018-01-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
|
EP3310779B1
(en)
|
2015-06-19 |
2019-05-08 |
Novartis AG |
Compounds and compositions for inhibiting the activity of shp2
|
ES2824576T3
(en)
|
2015-06-19 |
2021-05-12 |
Novartis Ag |
Compounds and compositions to inhibit SHP2 activity
|
EP3310774B1
(en)
|
2015-06-19 |
2020-04-29 |
Novartis AG |
Compounds and compositions for inhibiting the activity of shp2
|
FR3037952B1
(en)
|
2015-06-24 |
2019-01-25 |
Compagnie Generale Des Etablissements Michelin |
PROCESS FOR THE SYNTHESIS OF AROMATIC OXIMES
|
EP3112440B1
(en)
|
2015-07-02 |
2019-07-24 |
Merck Patent GmbH |
Liquid-crystal medium
|
EP3325447A1
(en)
|
2015-07-22 |
2018-05-30 |
Araxes Pharma LLC |
Substituted quinazoline compounds and their use as inhibitors of g12c mutant kras, hras and/or nras proteins
|
GB201514015D0
(en)
|
2015-08-07 |
2015-09-23 |
Arnér Elias S J And Dept Of Health And Human Services |
Novel pyridazinones and their use in the treatment of cancer
|
GB201514018D0
(en)
|
2015-08-07 |
2015-09-23 |
Arnér Elias S J And United States Of America Asrepresented By The Sec Dep Of Health And Human Servic |
Novel tricyclic compounds and their use in the treatment of cancer
|
CA2995325A1
(en)
|
2015-08-12 |
2017-02-16 |
Mochida Pharmaceutical Co., Ltd. |
Isothiazole derivative
|
EP3133078B1
(en)
|
2015-08-18 |
2019-01-30 |
Samsung Electronics Co., Ltd. |
Organometallic compound and organic light-emitting device including the same
|
KR101796227B1
(en)
|
2015-08-21 |
2017-11-10 |
삼성디스플레이 주식회사 |
Organic light-emitting device
|
US10240085B2
(en)
|
2015-08-27 |
2019-03-26 |
Samsung Electronics Co., Ltd. |
Thin film and organic light-emitting device including the same
|
KR102542465B1
(en)
|
2015-09-22 |
2023-06-12 |
삼성전자주식회사 |
Organometallic compound and organic light emitting device including the same
|
WO2017058915A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10882847B2
(en)
|
2015-09-28 |
2021-01-05 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
WO2017058805A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017058768A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017058902A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10858343B2
(en)
|
2015-09-28 |
2020-12-08 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10875842B2
(en)
|
2015-09-28 |
2020-12-29 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
SE541053C2
(en)
|
2015-09-30 |
2019-03-19 |
Epiroc Rock Drills Ab |
System and method for drilling plan generation, drilling rig, computer program and computer program product
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
JP2018533939A
(en)
|
2015-10-19 |
2018-11-22 |
アラクセス ファーマ エルエルシー |
Method for screening for inhibitors of RAS
|
EP3162875B1
(en)
|
2015-10-30 |
2018-05-23 |
Merck Patent GmbH |
Polymerisable compounds and the use thereof in liquid-crystal displays
|
WO2017077280A1
(en)
|
2015-11-02 |
2017-05-11 |
Sonia Lain |
Tetrahydroindazoles and medical uses thereof
|
EA038635B9
(en)
|
2015-11-16 |
2021-10-26 |
Араксис Фарма Ллк |
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
|
US9988357B2
(en)
|
2015-12-09 |
2018-06-05 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
KR20170069342A
(en)
|
2015-12-10 |
2017-06-21 |
삼성디스플레이 주식회사 |
Organic light-emitting device
|
CN106892924B
(en)
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
Short-acting benzodiazepine derivatives, method for the production thereof and use thereof
|
KR20170075118A
(en)
|
2015-12-22 |
2017-07-03 |
삼성디스플레이 주식회사 |
Organic light emitting device
|
KR102579752B1
(en)
|
2015-12-22 |
2023-09-19 |
삼성디스플레이 주식회사 |
Organic light emitting device
|
US10336772B2
(en)
|
2015-12-28 |
2019-07-02 |
Samsung Electronics Co., Ltd. |
Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound
|
KR102419178B1
(en)
|
2015-12-29 |
2022-07-11 |
삼성디스플레이 주식회사 |
Organic light-emitting device
|
KR102396293B1
(en)
|
2015-12-29 |
2022-05-11 |
삼성디스플레이 주식회사 |
Organic light-emitting device
|
US10072017B2
(en)
|
2015-12-30 |
2018-09-11 |
Flatley Discovery Lab, Llc |
Compounds and methods for the treatment of cystic fibrosis
|
EP3190164B1
(en)
|
2016-01-05 |
2019-07-24 |
Samsung Electronics Co., Ltd |
Composition, thin film including the composition, and organic light-emitting device including the composition or the thin film
|
KR102633852B1
(en)
|
2016-01-25 |
2024-02-07 |
삼성디스플레이 주식회사 |
Carbazole-based compound and organic light emitting device comprising the same
|
US10562872B2
(en)
|
2016-02-08 |
2020-02-18 |
H. Lundbeck A/S |
Synthesis of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
|
KR102628850B1
(en)
|
2016-03-07 |
2024-01-25 |
삼성디스플레이 주식회사 |
Condensed cyclic compound and organic light emitting device comprising the same
|
EP3426654B1
(en)
|
2016-03-09 |
2021-10-20 |
President and Fellows of Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
HUE061989T2
(en)
|
2016-03-16 |
2023-09-28 |
Kura Oncology Inc |
Substituted thieno[2,3-d]pyrimidine derivatives as inhibitors of menin-mll and methods of use
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
WO2017170263A1
(en)
|
2016-03-31 |
2017-10-05 |
株式会社Dnpファインケミカル |
Photosensitive coloring resin composition, color filter and method for producing same, and display device
|
KR102606277B1
(en)
|
2016-04-06 |
2023-11-27 |
삼성디스플레이 주식회사 |
Organic light emitting device
|
KR102642199B1
(en)
|
2016-04-07 |
2024-03-05 |
삼성디스플레이 주식회사 |
Organic light emitting device
|
AU2017266911B2
(en)
|
2016-05-18 |
2021-09-02 |
Array Biopharma, Inc. |
KRas G12C inhibitors
|
KR20170138614A
(en)
|
2016-06-07 |
2017-12-18 |
삼성디스플레이 주식회사 |
Organic light emitting device comprising the same
|
EP3464272B1
(en)
*
|
2016-06-07 |
2021-12-08 |
Jacobio Pharmaceuticals Co., Ltd. |
Novel heterocyclic derivatives useful as shp2 inhibitors
|
RU2744988C2
(en)
|
2016-06-14 |
2021-03-17 |
Новартис Аг |
Compounds and compositions for suppressing shp2 activity
|
CN109661228A
(en)
|
2016-06-20 |
2019-04-19 |
库拉肿瘤学公司 |
With ERK inhibitor for treating squamous cell carcinoma
|
US20180002604A1
(en)
|
2016-06-30 |
2018-01-04 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
CN116478131A
(en)
*
|
2016-07-12 |
2023-07-25 |
锐新医药公司 |
2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors
|
US11299673B2
(en)
|
2016-08-12 |
2022-04-12 |
Merck Patent Gmbh |
Liquid-crystal medium
|
KR20180019803A
(en)
|
2016-08-16 |
2018-02-27 |
삼성디스플레이 주식회사 |
Organic light emitting device
|
EP3515916B1
(en)
|
2016-09-22 |
2023-06-07 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
JP6589795B2
(en)
|
2016-09-27 |
2019-10-16 |
信越化学工業株式会社 |
Sulfonium salt, resist composition and pattern forming method
|
WO2018060110A1
(en)
|
2016-09-28 |
2018-04-05 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
CN110036010A
(en)
|
2016-09-29 |
2019-07-19 |
亚瑞克西斯制药公司 |
The inhibitor of KRAS G12C mutain
|
JP7020420B2
(en)
|
2016-09-29 |
2022-02-16 |
住友化学株式会社 |
Light emitting element
|
EP3523289A1
(en)
|
2016-10-07 |
2019-08-14 |
Araxes Pharma LLC |
Heterocyclic compounds as inhibitors of ras and methods of use thereof
|
JP7083823B2
(en)
|
2016-10-13 |
2022-06-13 |
ブリストル-マイヤーズ スクイブ カンパニー |
Heterocyclic sulfones as RORγ modifiers
|
TW201819386A
(en)
|
2016-10-24 |
2018-06-01 |
美商傳達治療有限公司 |
SHP2 phosphatase inhibitors and methods of use thereof
|
CN110278711B
(en)
|
2016-11-09 |
2023-12-15 |
百时美施贵宝公司 |
Tricyclosulfones as rory modulators
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
BR112019012976A2
(en)
|
2016-12-22 |
2019-12-31 |
Amgen Inc |
kras g12c inhibitors and methods of using them
|
RU2769132C2
(en)
|
2017-01-10 |
2022-03-28 |
Новартис Аг |
Pharmaceutical combination containing alk inhibitor and shp2 inhibitor
|
KR20190111079A
(en)
|
2017-01-23 |
2019-10-01 |
레볼루션 메디슨즈, 인크. |
Bicyclic Compounds as Allosteric SHP2 Inhibitors
|
BR112019014527A2
(en)
|
2017-01-23 |
2020-02-27 |
Revolution Medicines, Inc. |
PYRIDINE COMPOUNDS AS ALLOSTIC SHP2 INHIBITORS
|
MX2019009351A
(en)
|
2017-02-07 |
2019-09-19 |
Oblique Therapeutics Ab |
Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer.
|
CN110382480A
(en)
|
2017-02-07 |
2019-10-25 |
欧比力克治疗公司 |
The pyridine and its purposes in cancer treatment that heterocyclyl sulfonyl replaces
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
KR102317480B1
(en)
|
2017-03-23 |
2021-10-25 |
자코바이오 파마슈티칼스 컴퍼니 리미티드 |
Novel heterocyclic derivatives useful as SHP2 inhibitors
|
KR102395784B1
(en)
|
2017-03-27 |
2022-05-10 |
삼성전자주식회사 |
Organometallic compound and organic light emitting device including the same
|
KR102461719B1
(en)
|
2017-05-23 |
2022-11-01 |
삼성전자주식회사 |
Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
|
WO2018218133A1
(en)
|
2017-05-26 |
2018-11-29 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
WO2018230595A1
(en)
|
2017-06-14 |
2018-12-20 |
富士フイルム株式会社 |
Composition, film, lens, solid state imaging element, and compound
|
KR20180137311A
(en)
|
2017-06-16 |
2018-12-27 |
삼성전자주식회사 |
Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
|
EP3645528A1
(en)
|
2017-06-26 |
2020-05-06 |
Esteve Pharmaceuticals, S.A. |
Compounds having multimodal activity against pain
|
WO2019018119A1
(en)
|
2017-07-18 |
2019-01-24 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnti related conditions
|
KR20190014187A
(en)
|
2017-07-27 |
2019-02-12 |
삼성디스플레이 주식회사 |
Organometallic compound and organic light-emitting device including the same
|
GB201712110D0
(en)
|
2017-07-27 |
2017-09-13 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
New compounds and uses
|
JP7346015B2
(en)
|
2017-09-06 |
2023-09-19 |
住友化学株式会社 |
light emitting element
|
CN111344017A
(en)
|
2017-09-07 |
2020-06-26 |
锐新医药公司 |
SHP2 inhibitor compositions and methods for treating cancer
|
CA3074304A1
(en)
|
2017-09-11 |
2019-03-14 |
Krouzon Pharmaceuticals, Inc. |
Octahydrocyclopenta[c]pyrrole allosteric inhibitors of shp2
|
KR102526756B1
(en)
|
2017-09-29 |
2023-04-27 |
삼성전자주식회사 |
Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
|
US11299676B2
(en)
|
2017-09-29 |
2022-04-12 |
Merck Patent Gmbh |
Polymerisable compounds and the use thereof in liquid-crystal displays
|
WO2019067843A1
(en)
|
2017-09-29 |
2019-04-04 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
JP2020536881A
(en)
|
2017-10-12 |
2020-12-17 |
レヴォリューション・メディスンズ,インコーポレイテッド |
Pyridine, pyrazine and triazine compounds as allosteric SHP2 inhibitors
|
KR102518722B1
(en)
|
2017-11-21 |
2023-04-07 |
삼성디스플레이 주식회사 |
Organometallic compound and organic light emitting device comprising the same
|
MX2020006273A
(en)
|
2017-12-15 |
2020-09-14 |
Revolution Medicines Inc |
Polycyclic compounds as allosteric shp2 inhibitors.
|
MX2020006614A
(en)
|
2017-12-22 |
2020-11-06 |
Ravenna Pharmaceuticals Inc |
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors.
|
US11572370B2
(en)
|
2018-01-08 |
2023-02-07 |
Biohaven Therapeutics Ltd. |
CD16A binding agents and uses thereof
|
KR102595918B1
(en)
|
2018-01-18 |
2023-11-14 |
삼성디스플레이 주식회사 |
Organometallic compound, organic light emitting device comprising the same and organic emitting apparatus comprising the organic light emitting device
|
CN110066277B
(en)
|
2018-01-24 |
2021-07-23 |
上海璎黎药业有限公司 |
Aromatic heterocyclic substituted olefin compound, preparation method, pharmaceutical composition and application thereof
|
CN110066276B
(en)
|
2018-01-24 |
2020-09-18 |
上海璎黎药业有限公司 |
Aromatic heterocyclic compound, intermediate thereof, preparation method, pharmaceutical composition and application
|
KR20190098676A
(en)
|
2018-02-13 |
2019-08-22 |
삼성디스플레이 주식회사 |
Organic light emitting device and display apparatus comprising the same
|
JP7335882B2
(en)
|
2018-02-13 |
2023-08-30 |
ブルーレイ セラピューティクス (シャンハイ) カンパニー,リミティド |
Pyrimidine-condensed ring compound, method for producing the same, and use
|
WO2019165073A1
(en)
|
2018-02-21 |
2019-08-29 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
SG11202006778TA
(en)
|
2018-03-02 |
2020-08-28 |
Otsuka Pharma Co Ltd |
Pharmaceutical compounds
|
EP3537495A1
(en)
|
2018-03-08 |
2019-09-11 |
Samsung Display Co., Ltd. |
Organic light-emitting device
|
US11004918B2
(en)
|
2018-03-09 |
2021-05-11 |
Samsung Display Co., Ltd. |
Electronic apparatus
|
RU2020133727A
(en)
|
2018-03-21 |
2022-04-21 |
Сучжоу Пухе Биофарма Ко., Лтд. |
SHP2 INHIBITORS AND THEIR USE
|
US20220315586A1
(en)
|
2018-03-21 |
2022-10-06 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
US20210069188A1
(en)
|
2018-03-21 |
2021-03-11 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof
|
CN108794485B
(en)
|
2018-04-28 |
2020-04-24 |
北京施安泰医药技术开发有限公司 |
Toll-like receptor modulators, pharmaceutical composition, preparation method and application thereof
|
US10954243B2
(en)
|
2018-05-02 |
2021-03-23 |
Navire Pharma, Inc. |
Substituted heterocyclic inhibitors of PTPN11
|
CN110492006B
(en)
|
2018-05-14 |
2020-06-12 |
江苏三月光电科技有限公司 |
Electroluminescent device based on boron-containing organic compound
|
CN108840886A
(en)
|
2018-06-22 |
2018-11-20 |
南京工业大学 |
A kind of platinum complex blue light material and organic luminescent device
|
MA53395A
(en)
|
2018-07-24 |
2021-06-02 |
Otsuka Pharma Co Ltd |
HETEROBICYCLIC COMPOUNDS TO INHIBIT SHP2 ACTIVITY
|
CN108863982B
(en)
|
2018-08-04 |
2022-02-01 |
南昌航空大学 |
Organic electrosynthesis method of phenothiazine/phenoxazine compounds
|
WO2020033286A1
(en)
|
2018-08-06 |
2020-02-13 |
Purdue Research Foundation |
Novel sesquiterpenoid analogs
|
EP4356973A2
(en)
|
2018-08-10 |
2024-04-24 |
Navire Pharma, Inc. |
6-(4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3h)-one derivatives and related compounds as ptpn11 (shp2) inhibitors for treating cancer
|
EP3853233A1
(en)
|
2018-09-18 |
2021-07-28 |
Nikang Therapeutics, Inc. |
Tri-substituted heteroaryl derivatives as src homology-2 phosphatase inhibitors
|
CA3113379A1
(en)
|
2018-09-29 |
2020-04-02 |
Novartis Ag |
Process of manufacture of a compound for inhibiting the activity of shp2
|
CA3112322A1
(en)
|
2018-09-29 |
2020-04-02 |
Novartis Ag |
Manufacture of compounds and compositions for inhibiting the activity of shp2
|
CN113473990A
(en)
|
2018-10-08 |
2021-10-01 |
锐新医药公司 |
SHP2 inhibitor composition for treating cancer
|